iota Biosciences, Inc. powered by Astellas

iota Biosciences, Inc. powered by Astellas

Medical Equipment Manufacturing

Alameda, California 8,115 followers

Where ingenious ideas become life-changing bioelectronics

About us

iota Biosciences, a wholly-owned subsidiary of Astellas Pharma US, is a medical device company working to develop pioneering bioelectronics to advance the treatment and management of disease. Founded in 2017 to build on the award-winning ultrasound technology invented at the University of California, Berkeley, iota Biosciences is committed to improving human life and bringing our groundbreaking approaches to the patients who need them. Using innovative science and technology, our mission is to create and develop state-of-the-art diagnostic and therapeutic bioelectronic devices that are safe and effective. We are working to transform the way doctors manage and treat disease to make a life-changing difference for patients. We are proud and privileged to be powered by Astellas, a leading global pharmaceutical company that brings experience, reach and rigor. With a shared transformational vision and a commitment to the realization of greater value to patients, together we are creating innovative technologies that will change patients’ lives.

Website
http://www.iota.bio
Industry
Medical Equipment Manufacturing
Company size
51-200 employees
Headquarters
Alameda, California
Type
Public Company
Founded
2017
Specialties
bioelectronic medicine, neuroengineering, ultrasound, nerve interfaces, brain-machine interfaces, medical devices, electroceuticals, implantable devices, and bioengineering

Locations

Employees at iota Biosciences, Inc. powered by Astellas

Updates

  • 🌟𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁𝗶𝗻𝗴 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗮𝘁 𝗶𝗼𝘁𝗮! 🌟 At iota, we love to recognize the hard work and dedication of our team! Each quarter, our 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗔𝘄𝗮𝗿𝗱𝘀 are given out to employees who exemplify our core values of 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝗴𝗿𝗼𝘄𝘁𝗵 𝗺𝗶𝗻𝗱𝘀𝗲𝘁, 𝗼𝘂𝘁𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗲𝘅𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝗮𝗹 𝘀𝗲𝗹𝗳-𝗺𝗼𝘁𝗶𝘃𝗮𝘁𝗶𝗼𝗻. 🏆✨ 🥇 These awards are based upon colleagues who vote to acknowledge those who have led by example and inspired others.  As this quarter comes to a close, join us in celebrating Sameer Shaik, Izumi Shimanouchi, and Haygan Ngo, PMP! We couldn’t be prouder to have them on our team! 🙌👏 

    • No alternative text description for this image
  • ✨ 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗟𝗶𝘃𝗲𝘀, 𝗢𝗻𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝗮 𝗧𝗶𝗺𝗲 ✨  Did you know that millions of patients worldwide with 𝘂𝗻𝗱𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 (UAB) rely on intermittent self-catheterization or permanent catheters to empty their bladder?  These patients face a lifelong burden of catheterization, along with the risk of serious complications. Currently, there are no viable solutions to restore their natural bladder function.  At iota, we’re proud to pioneer a 𝗳𝗶𝗿𝘀𝘁-𝗶𝗻-𝗵𝘂𝗺𝗮𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗼𝗳 𝗮 𝗯𝗹𝗮𝗱𝗱𝗲𝗿 𝗶𝗺𝗽𝗹𝗮𝗻𝘁 that empowers patients to empty their bladder on demand and potentially restore bladder function. This groundbreaking technology has received FDA IDE approval — a monumental step toward transforming the lives of those with UAB. 🚀  Follow us to stay updated on this exciting journey!  #UnderactiveBladder #MedTech #QualityOfLife #Innovation #IDE 

  • 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗮𝘁 𝗶𝗼𝘁𝗮 𝗕𝗶𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀: 𝗪𝗲𝗹𝗰𝗼𝗺𝗲 Jami A.H. Maccombs! 🎉 We are thrilled to announce that 𝗝𝗮𝗺𝗶 𝗠𝗮𝗰𝗰𝗼𝗺𝗯𝘀 has joined iota Biosciences as our new 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿 𝗼𝗳 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀. Jami brings a wealth of experience from her previous roles at 𝗠𝗲𝗱𝘁𝗿𝗼𝗻𝗶𝗰, 𝗔𝗯𝗯𝗼𝘁𝘁 and 𝗘𝗱𝘄𝗮𝗿𝗱𝘀 𝗟𝗶𝗳𝗲𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀. With her proven track record in clinical trial management, Jami’s leadership along with our Clinical team will be instrumental in propelling iota into its first 𝗘𝗮𝗿𝗹𝘆 𝗙𝗲𝗮𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝘀𝘁𝘂𝗱𝘆 for our 𝗨𝗻𝗱𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗕𝗹𝗮𝗱𝗱𝗲𝗿 𝗽𝗿𝗼𝗴𝗿𝗮𝗺.   𝗪𝗲𝗹𝗰𝗼𝗺𝗲, 𝗝𝗮𝗺𝗶! 👏

    • No alternative text description for this image
  • Happy Thanksgiving from iota! 🦃🍽️🍂 In honor of Thanksgiving coming up, iotans gathered last week for a Thanksgiving potluck to celebrate the Holiday with great food and company. We’re thankful for all our amazing teams, their hard work, and collaboration they bring to iota every day. Wishing everyone a Holiday Season filled with warmth and joy! ❤️ #Thanksgiving #Gratitude #iota 

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • We are excited to announce that we have received FDA IDE (investigational device exemption) approval for our investigational bladder stimulation device, a Class 3 Active Implantable designed for people with underactive bladder (UAB). This significant milestone allows us to move into the next phase of development for this therapy and assess its safety and feasibility in clinical trials.      UAB represents a huge area of unmet need, so our team has worked at pace while maintaining an uncompromising emphasis on quality to drive from concept to IDE approval in just four years – an unprecedented achievement!    At iota Biosciences, Inc. powered by Astellas, we’re focused on creating and developing state-of-the-art diagnostic and therapeutic bioelectronic devices to advance the treatment and management of disease. From day one we have combined speed, agility and quality to achieve our ambition of creating the next generation of innovative technologies, that will change lives.   Read the official press release: https://lnkd.in/dydXmytP Find out more about iota and the pioneering work we’re doing https://iota.bio/    #MedTech #FDA #IDE #Innovation 

    • No alternative text description for this image

Similar pages

Browse jobs

Funding